Is trust the key factor in digital HCP engagement? Explore this in our latest whitepaper
The webinar covers topics including:
How can pharma organisations earn the trust of HCPs when it comes to digital content and platforms?
How should we further engage Medical functions to build trust in the context of digital engagement and interaction?
What is the role of digital or technology in building trust? Is pharma doing enough when it comes to technology and digital customer experience?
In our recent research with HCPs, a staggering 80% cited a lack of trust in digital content and channels provided by pharma organisations.
The issue of low trust is one that pharma marketers have been facing for years. But in this new era of digital engagement, do our approaches need to evolve further?
Here, we delved into this theme in more detail and explored what pharma teams and organisations can do to build confidence and strengthen HCP relationships.
The panellists' views are their own, not those of their organisation.
The event was chaired by Rob Verheul, CEO at Graphite Digital, and featured an industry panel with:
Andrew Binns, Head of Digital and Innovation, AstraZeneca
Daniel Johnson, Head of BU GI, Neuroscience, Vaccines and Established Brands Switzerland, Takeda
Michelle Bridenbaker, Global Medical Information Lead at Idorsia / Vice President elect at Medical Information Leaders in Europe (MILE)
Maria Nieves Alvarado, Associate Director, Omnichannel Marketing Excellence - International Markets, Astellas Pharma